BamSEC and AlphaSense Join Forces
Learn More

Somanta Pharmaceuticals Inc.

Material Contracts Filter

EX-10.39
from 10QSB 3 pages Amendment to Common Stock Purchase Warrants and Notice of Warrant Exercise Dated August 17, 2007 Between the Company and Sco Financial Group LLC
12/34/56
EX-10.38
from 10QSB 3 pages Amendment to Common Stock Purchase Warrants and Notice of Warrant Exercise Dated August 17, 2007 Between the Company and Sco Capital Partners LLC
12/34/56
EX-10.37
from 10KSB ~20 pages Material contract
12/34/56
EX-10.36
from 10KSB ~10 pages Material contract
12/34/56
EX-10.35
from 10KSB ~5 pages Material contract
12/34/56
EX-10.34
from 10QSB 1 page Second Side Amendment to Patent and Know-How Exclusve Sublicense Agreement Dated August 18, 2005 and Its Side Amendment Dated November 3, 2006
12/34/56
EX-10.33
from 10QSB 8 pages Side Amendment to Patent and Know-How Exclusive Sublicense Agreement
12/34/56
EX-10.32
from 8-K 21 pages (B) the Parties Acknowledge That the Terms of This Agreement Are to Govern the Funding and Conduct of a Studentship, to Enable the Student to Carry Out a Research Project and Submit a Related Thesis for Examination in Accordance With Imperial’s Regulations Governing Post-Graduate Study in Fulfilment of the Requirements of a Higher Degree of Imperial. the Parties Further Acknowledge That the Research Is Intended to Lead to Academic Publications Relating to the Results of the Studentship in Furtherance of the Student’s Career. (C) the Parties Further Acknowledge That in the Course of the Studentship the Parties May Be Exposed to Proprietary and Commercially Valuable Information or Materials of the Sponsor and/or Imperial. All Parties Recognise the Importance of Holding in Confidence Such Information or Materials. 1. Definitions 1.1 in This Agreement the Following Expressions Shall Have the Following Meanings: 1.1.1 “Academic Supervisor” Means Dr Mahendra Deonarain or His or Her Successor, Appointed Under Clause 9.2. 1.1.2 “Affiliate” Means Any Company Which Directly or Indirectly Through One or More Intermediaries Controls, Is Controlled by or Is Under Common Control With the Sponsor
12/34/56
EX-10.11
from 8-K/A 45 pages Patent and Know-How Exclusive Sublicense Agreement
12/34/56
EX-10.10
from 8-K/A 27 pages Phenylbutyrate Co-Development and Sublicense Agreement by and Among Bridge Therapeutic Products, Inc and Bridge Oncology Products, Inc
12/34/56
EX-10.9
from 8-K/A 18 pages Confidentiality Treatment Requested
12/34/56
EX-10.22
from SB-2/A 9 pages Agreement Regarding Academic Clinical Study
12/34/56
EX-10.31
from 10KSB 1 page Somanta Incorporated Second Amendment to Service Provision Agreement
12/34/56
EX-10.10
from SB-2/A 26 pages Phenylbutyrate Co-Development and Sublicense Agreement by and Among Bridge Therapeutic Products, Inc and Bridge Oncology Products, Inc
12/34/56
EX-10.19
from 8-K/A 19 pages Collaborative Research Agreement
12/34/56
EX-10.7
from 8-K/A 24 pages Patent and Know-How Assignment and License Option Agreement
12/34/56
EX-10.30
from 10KSB 1 page Somanta Incorporated Amendment to Service Provision Agreement
12/34/56
EX-10.29
from SB-2/A 3 pages Somanta Limited
12/34/56
EX-10.28
from SB-2/A 4 pages Sco Financial Group LLC March 1, 2005
12/34/56
EX-10.27
from SB-2/A 9 pages Dated the 15th Day of May 2006 Hca International Limited Registered Office 4 Connaught Place, London W2 2et Trading As: The Harley Street Clinic 35 Weymouth Street London Wig 8bj Licence to Occupy Consulting Room(s) at 80 Harley Street 1 of 9 Contents
12/34/56